4 GLP-1 agonist therapy is an evolving and more acceptable treatment for T2DM regardless of the degree of A1C control
Many residents choose IV therapy because it allows precise dosage and consistent absorption
Its very stressful for patients who have been doing really well, who are having good tolerance and feel like they have hit their stride in terms of medication, nutrition and exercise
The debate over precursors often misses the bigger picture: delivery and conversion
The introduction of generics, such as Glenmarks liraglutide biosimilar launched at dramatically lower prices, reflects the push toward affordability and broader access in a cost-conscious market
As the use of GLP-1 RA expands, ongoing monitoring of side effects, especially those that are underrecognized in clinical settings, is essential for a better understanding of patient experiences and guiding future studies